FDA Releases Three Lots Of Chiron's Fluvirin
This article was originally published in The Pink Sheet Daily
Executive Summary
Chiron received approval for its flu vaccine Sept. 14 after adequately addressing FDA's manufacturing concerns.
You may also be interested in...
Chiron’s Adjuvant Could Quadruple Flu Vaccine Capacity, CEO Pien Says
The firm will meet with FDA to determine the regulatory pathway for the MF59 adjuvant in 2006.
Chiron’s Adjuvant Could Quadruple Flu Vaccine Capacity, CEO Pien Says
The firm will meet with FDA to determine the regulatory pathway for the MF59 adjuvant in 2006.
FDA Assembles Pandemic Flu Task Force
Members of the Task Force on Pandemic Influenza will be culled from 14 agency offices.